AOD-9604 is a synthetic peptide based on a modified fragment of human growth hormone. It is not full-length HGH, and structural relatedness does not establish human fat-loss benefits or safety.
What the weight evidence shows
FDA’s 2024 evaluation describes a major obesity study without a statistically significant weight-loss difference versus placebo and concludes that effectiveness evidence for treating obesity is lacking.
Why a proposed mechanism is not an outcome
Molecular or animal work helps frame research questions. It should not replace human trial outcomes or verify a product labelled AOD-9604.
Safety-evidence limitations
Limited information does not establish safety. Assurances of no hormonal effects or no adverse effects exceed the evidence cited here.
Frequently asked questions
Is AOD-9604 the same as HGH?
No. It is based on a modified HGH fragment, not the full hormone.
Is human weight-loss effectiveness established here?
The cited FDA evaluation does not support that conclusion for treating obesity.
Does the word peptide mean safe?
No. A substance class does not establish product quality, safety or authorization.
Read next
What is MOTS-c? Mitochondrial peptide and evidence · What is SLU-PP-332? ERR targets and research limits · HGH / Somatropin
Sources
Information checked 10 September 2026. Research and medicine labels above are separate from evidence for this listing image.
For general name or label questions, contact LINE: @musclestationth
Revision note
Earlier fat-loss promises and minimization of adverse effects remain withdrawn.